Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during

Shaaban A Mousa1, Mohammed Shaqura, Jens Winkler

  • 1Department of Anaesthesiology and Intensive Care Medicine, Charité University Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany Department of Anatomy, Ludwig Maximilian University Munich, Munich, Germany Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Jena, Germany Department of Internal Medicine, Paulinenkrankenhaus, Berlin, Germany.

Pain
|December 30, 2015
PubMed

Insights

Diabetic neuropathy impairs opioid pain relief by reducing mu-opioid receptor (MOR) function. This study reveals a RAGE-dependent PKC pathway causes MOR desensitization in sensory neurons, offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Endocrinology

Background:

  • Painful diabetic neuropathy is linked to reduced opioid effectiveness.
  • The exact mechanisms behind this impaired analgesia in sensory neurons are not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of altered opioid responsiveness in early streptozotocin-induced diabetes in rats.
  • To identify key molecular players in sensory neurons contributing to impaired opioid analgesia.

Main Methods:

  • Utilized streptozotocin-induced diabetes model in rats.
  • Examined mu-opioid receptor (MOR) G protein coupling and phosphorylation.
  • Investigated the roles of Protein Kinase C (PKC), Receptor for Advanced Glycation End Products (RAGE), and advanced glycation end products (AGEs).
  • Employed PKC inhibitors, RAGE siRNA, and AGE formation inhibitors.

Main Results:

  • Diabetic rats showed reduced functional MOR G protein coupling and impaired peripheral opioid analgesia.
  • MORs in sensory neurons colocalized with activated PKC and RAGE.
  • MOR phosphorylation at Thr370, leading to desensitization, was mediated by RAGE-dependent PKC activation.
  • Interventions targeting PKC, RAGE, or AGE formation restored MOR function and analgesic efficacy.

Conclusions:

  • Demonstrated in vivo evidence of RAGE-dependent, PKC-mediated heterologous MOR phosphorylation and desensitization in sensory neurons during diabetic neuropathy.
  • Identified a novel mechanism contributing to impaired opioid responsiveness in diabetes.
  • Suggests potential therapeutic strategies for preventing or reversing opioid resistance in diabetic neuropathy.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.4K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K